{"title":"Correction to “the effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography”","authors":"","doi":"10.1002/ibra.12141","DOIUrl":null,"url":null,"abstract":"<p>Tan D-D, Gu J, Li J, et al. The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography. <i>ibrain</i>. 2023;9:290-297. doi:10.1002/ibra.12072</p><p>In “CONFLICT OF INTEREST” section, the text “Jin Tian is a member of Ibrain's editorial board, but is not involved in the peer-review process of this article. The remaining authors declare no conflict of interest.” was inaccurate.</p><p>The correct statement in the CONFLICT OF INTEREST section should be presented as “Jin Tian is a member of Ibrain's editorial board, but is not involved in the peer-review process of this article. Guo-Hua Zhu is affiliated with Yichang Humanwell Pharmaceutical Co., Ltd, Yichang, Hubei, China. He confirms that he has no commercial and other conflicting interests that could be produced from this manuscript. The remaining authors declare no conflict of interest.”</p><p>We apologize for this error.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"116"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12141","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ibrain","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ibra.12141","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Tan D-D, Gu J, Li J, et al. The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography. ibrain. 2023;9:290-297. doi:10.1002/ibra.12072
In “CONFLICT OF INTEREST” section, the text “Jin Tian is a member of Ibrain's editorial board, but is not involved in the peer-review process of this article. The remaining authors declare no conflict of interest.” was inaccurate.
The correct statement in the CONFLICT OF INTEREST section should be presented as “Jin Tian is a member of Ibrain's editorial board, but is not involved in the peer-review process of this article. Guo-Hua Zhu is affiliated with Yichang Humanwell Pharmaceutical Co., Ltd, Yichang, Hubei, China. He confirms that he has no commercial and other conflicting interests that could be produced from this manuscript. The remaining authors declare no conflict of interest.”
Tan D-D，Gu J，Li J，et al.The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography.ibrain.2023;9:290-297.DOI:10.1002/ibra.12072在 "利益冲突 "部分，"Jin Tian是Ibrain编辑委员会成员，但未参与本文的同行评审过程。在利益冲突部分，正确的表述应为 "田进是 Ibrain 编辑委员会成员，但未参与本文的同行评审过程。朱国华隶属于中国湖北宜昌人福药业有限公司。他确认自己在本稿件中没有任何商业或其他利益冲突。其余作者声明没有利益冲突。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
